The Healthcare Data Institute is pleased to present its second White Paper: "Big Data & Prevention: from Prediction to Demonstration"
Le Healthcare Data Institute est heureux de présenter son deuxième Livre blanc “Big Data et Prévention : de la prédiction à la démonstration”.
What was the hottest topic in gut microbiota science this year? Many experts would say it was the study of interactions between gut microbiota and the immune system.
The Healthcare Data Institute was launched in partnership with several companies representative of the Big Data health ecosystem. Its Board of Directors gathers representatives from Aviesan, CEA, IMS Health, McKinsey&Company, Medbiomix, Orange Healthcare, Sanofi, Vitalia. The Healthcare Data Institute is acting as a forward- thinking catalyst in France and internationally. It aims to develop thought leadership on Big Data for healthcare, be a catalyst for ideas, and foster the emergence of concrete projects
Gut microbiota and inflammatory bowel disease: A selection of content from the Gut Microbiota for Health Experts Exchange 2014-2015 Inflammatory Bowel Disease (IBD) research has made some exciting progress in the past decade, thanks to the myriad studies investigating the role of the gut microbiota. The Gut Microbiota for Health Experts Exchange has covered Crohn’s disease and ulcerative colitis more than any other topics and, reflecting the importance of intestinal microbiota in IBD. Moreover, the European Crohn’s and Colitis Organisation (ECCO-IBD) who share a common interest in the gut microbiota, has joined the European Society of Neurogastroenterology & Motility (ESNM) Gut Microbiota & Health Section in 2015.
Lancement du premier Think Tank international consacré au Big Data dans le domaine de la santé : le Healthcare Data Institute. Orange Healthcare lance le Healthcare Data Institute avec plusieurs acteurs dont le CEA, le cabinet Desmarais Avocats, IMS Health, McKinsey et le Groupe Vitalia.